We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

Sort By:
page of 1

HHLA2 Peptides and Proteins

We offer B7-H7/HHLA2 Peptides and B7-H7/HHLA2 Proteins for use in common research applications: ELISA, Protein Array, Western Blot. Each B7-H7/HHLA2 Peptide and B7-H7/HHLA2 Protein is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our B7-H7/HHLA2 Peptides and B7-H7/HHLA2 Proteins can be used in a variety of model species: Human. Use the list below to choose the B7-H7/HHLA2 Peptide and B7-H7/HHLA2 Protein which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our B7-H7/HHLA2 Peptides and Proteins.
Alternate Names for HHLA2 Peptides and Proteins
B7-H7/HHLA2 protein, HHLA2 protein, HERV-H LTR-associating 2 protein, HERV-H LTR-associating protein 2 protein, Human endogenous retrovirus-H long terminal repeat-associating protein 2 protein
6 Results for "b7-h7-hhla2" in Peptides and Proteins
50 μg
8316-TR) is coated at 2 µg/mL (100 µL/well), Recombinant Cynomolgus B7-H7/HHLA2 (Catalog # 10109-B7) binds with an ED50 of 0.2-1.2 µg/mL" class="big_lightbox"> 8316-TR) is coated at 2 µg/mL (100 µL/well), Recombinant Cynomolgus B7-H7/HHLA2 (Catalog # 10109-B7) binds with an ED50 of 0.2-1.2 µg/mL" alt="When Recombinant Human TMIGD2/CD28H Fc Chimera (Catalog # 8316-TR) is coated at 2 µg/mL (100 µL/well), Recombinant Cynomolgus B7-H7/HHLA2 (Catalog # 10109-B7) binds with an ED50 of 0.2-1.2 µg/mL" class="big_thumb" />
Pm-Cm
Species Glossary
Reactivity: Pm-Cm
Bioactivity
Applications: Bioactivity
compare
(select up to 3 products from this page to compare)
50 μg
Pm-Cm
Species Glossary
Reactivity: Pm-Cm
Bioactivity
Applications: Bioactivity
compare
(select up to 3 products from this page to compare)
100 μg
8316-TR) is immobilized at 2.5 μg/mL (100 μL/well), Recombinant Human B7 H7/HHLA2 His-tag (Catalog # 10475-B7) that produces a 50% optimal binding response is found to be 0.8-4.8 μg/mL." class="big_lightbox"> 8316-TR) is immobilized at 2.5 μg/mL (100 μL/well), Recombinant Human B7 H7/HHLA2 His-tag (Catalog # 10475-B7) that produces a 50% optimal binding response is found to be 0.8-4.8 μg/mL." alt="When Recombinant Human TMIGD2/CD28H (8316-TR) is immobilized at 2.5 μg/mL (100 μL/well), Recombinant Human B7 H7/HHLA2 His-tag (Catalog # 10475-B7) that produces a 50% optimal binding response is found to be 0.8-4.8 μg/mL." class="big_thumb" />
Hu
Species Glossary
Reactivity: Hu
Bioactivity
Applications: Bioactivity
compare
(select up to 3 products from this page to compare)
50 μg
G-102-C)." class="big_lightbox"> G-102-C)." alt="Recombinant Human B7-H7/HHLA2 Fc Chimera (Catalog # 8084-B7) inhibits anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 0.075-0.75 µg/mL in the presence of Goat Anti-Human IgG Fc Polyclonal Antibody (Catalog # G-102-C)." class="big_thumb" />
Hu
Species Glossary
Reactivity: Hu
Bioactivity
Applications: Bioactivity
compare
(select up to 3 products from this page to compare)
50 μg
8316-TR) with an ED50 of < 100 ng/mL." class="big_lightbox"> 8316-TR) with an ED50 of < 100 ng/mL." alt="Biotinylated Recombinant Human B7-H7/HHLA2 Fc Chimera binds to Recombinant TMIGD2/CD28H Fc Chimera (Catalog # 8316-TR) with an ED50 of < 100 ng/mL." class="big_thumb" />
Hu
Species Glossary
Reactivity: Hu
Bioactivity
Applications: Bioactivity
compare
(select up to 3 products from this page to compare)
0.1 ml
Hu
Species Glossary
Reactivity: Hu
AC
Applications: AC
compare
(select up to 3 products from this page to compare)
page of 1